Immunogenic composition
US-11241495-B2 · Feb 8, 2022 · US
Immunogenic composition
US10166287B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10166287-B2 |
| Application number | US-201715691440-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 30, 2017 |
| Priority date | Jun 27, 2005 |
| Publication date | Jan 1, 2019 |
| Grant date | Jan 1, 2019 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
present application discloses an immunogenic composition comprising N. meningitidis capsular polysaccharides from at least one of serogroups A, C, W135 and Y conjugated to a carrier protein to produce a N. meningitidis capsular polysaccharide conjugate, wherein the average size of each N. meningitidis polysaccharide is above 50 kDa.
First claim
Opening claim text (preview).
The invention claimed is: 1. An immunogenic composition, comprising N. meningitidis capsular polysaccharides from serogroups A, C, W, and Y, wherein: the serogroup A capsular polysaccharide has an average size of 300 kDa; the serogroup C capsular polysaccharide has an average size of 200 kDa; the serogroup Y capsular polysaccharide has an average size of 101-300 kDa; the serogroup W capsular polysaccharide has an average size of 101-300 kDa; and wherein each N. meningitidis capsular polysaccharide is a N. meningitidis capsular polysaccharide conjugate comprising a N. meningitidis capsular polysaccharide conjugated to a tetanus toxoid carrier protein. 2. The immunogenic composition of claim 1 , wherein the serogroup Y capsular polysaccharide has an average size of 190-300 kDa; and the serogroup W capsular polysaccharide has an average size of 190-300 kDa. 3. An immunogenic composition, comprising N. meningitidis capsular polysaccharides from serogroups A, C, W, and Y, wherein: each of serogroups A, W, and Y capsular polysaccharide has an average size of 101-300 kDa, the serogroup C capsular polysaccharide has an average size of 200 kDa, and wherein each N. meningitidis capsular polysaccharide is a N. meningitidis capsular polysaccharide conjugate comprising a N. meningitidis capsular polysaccharide conjugated to a tetanus toxoid carrier protein. 4. The immunogenic composition of claim 3 , wherein the serogroup Y capsular polysaccharide has an average size of 190-300 kDa; and the serogroup W capsular polysaccharide has an average size of 190-300 kDa.
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10166287B2 cover?
- present application discloses an immunogenic composition comprising N. meningitidis capsular polysaccharides from at least one of serogroups A, C, W135 and Y conjugated to a carrier protein to produce a N. meningitidis capsular polysaccharide conjugate, wherein the average size of each N. meningitidis polysaccharide is above 50 kDa.
- Who is the assignee on this patent?
- Glaxosmithkline Biologicals Sa
- What technology area does this patent fall under?
- Primary CPC classification A61K39/0017. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Jan 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).